GPT Healthcare Limited
Quick Take
- • Trading at 28.9× trailing earnings (16.6× forward)
- • Strong ROE at 17.5%
- • Low leverage (D/E 0.34)
- • Attractive dividend yield of 1.83%
- • Operating margin 13.7% · Net margin 9.6%
- • Profit growth +64.90% YoY · Beta 0.31
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 126 | +0.00% | +17.76% |
| Operating Profit | 26 | +4.00% | +36.84% |
| Net Profit | 13 | -13.33% | +62.50% |
| EPS (₹) | 1.55 | -12.92% | +64.89% |
About the company
From latest AR & concallGPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and pharmacies, as well as the ILS Agartala Nursing Institute. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
